Scavenger Receptor Class B Type i Regulates Plasma Apolipoprotein e Levels and Dietary Lipid Deposition to the Liver

Biochemistry

Volumn 54, Issue 36, 2015, Pages 5605-5616

  Karavia, Eleni A ^a   Papachristou, Nikolaos I ^a   Sakellaropoulos, George C ^a   Xepapadaki, Eva ^a   Papamichail, Eleni ^a   Petropoulou, Peristera Ioanna ^a   Papakosta, Eugenia P ^a   Constantinou, Caterina ^a   Habeos, Ioannis ^a   Papachristou, Dionysios J ^a   Kypreos, Kyriakos E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEPOSITION; FATTY ACIDS; FLOOD CONTROL; GENE EXPRESSION; LIPIDS; MAMMALS;

ADENOSINE MONOPHOSPHATE; APOLIPOPROTEIN E (APOE); DIET-INDUCED OBESITY; FATTY ACID SYNTHESIS; GENE EXPRESSION ANALYSIS; HIGH-DENSITY LIPOPROTEINS; MITOCHONDRIAL FUNCTION; TRIGLYCERIDE-RICH LIPOPROTEINS;

LIPOPROTEINS;

APOLIPOPROTEIN E; FATTY ACID; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; FAT INTAKE; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; SCARB1 PROTEIN, MOUSE; SCAVENGER RECEPTOR B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; FAT INTAKE; FATTY ACID SYNTHESIS; FEMALE; GENE EXPRESSION; GLUCOSE INTOLERANCE; LIPID LIVER LEVEL; LIPID STORAGE; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MITOCHONDRION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; ENERGY METABOLISM; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; DIETARY FATS; ENERGY METABOLISM; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIVER; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; SCAVENGER RECEPTORS, CLASS B; TRIGLYCERIDES;

EID: 84941710761     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/acs.biochem.5b00700     Document Type: Article

References (55)

1. Krieger, M. (1999) Charting the fate of the good cholesterol: identification and characterization of the high-density lipoprotein receptor SR-BI Annu. Rev. Biochem. 68, 523-558 10.1146/annurev.biochem.68.1.523
2. Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., and Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 271, 518-520 10.1126/science.271.5248.518
3. Landschulz, K. T., Pathak, R. K., Rigotti, A., Krieger, M., and Hobbs, H. H. (1996) Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat J. Clin. Invest. 98, 984-995 10.1172/JCI118883
4. Acton, S. L., Scherer, P. E., Lodish, H. F., and Krieger, M. (1994) Expression cloning of SR-BI, a CD36-related class B scavenger receptor J. Biol. Chem. 269, 21003-21009
5. Swarnakar, S., Temel, R. E., Connelly, M. A., Azhar, S., and Williams, D. L. (1999) Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester J. Biol. Chem. 274, 29733-29739 10.1074/jbc.274.42.29733
6. de la Llera-Moya, M., Connelly, M. A., Drazul, D., Klein, S. M., Favari, E., Yancey, P. G., Williams, D. L., and Rothblat, G. H. (2001) Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL J. Lipid Res. 42, 1969-1978
7. Tall, A. R. (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 263, 256-273 10.1111/j.1365-2796.2007.01898.x
8. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., and Hobbs, H. H. (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters Science 290, 1771-1775 10.1126/science.290.5497.1771
9. Gillotte-Taylor, K., Boullier, A., Witztum, J. L., Steinberg, D., and Quehenberger, O. (2001) Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein J. Lipid Res. 42, 1474-1482
10. Sun, B., Boyanovsky, B. B., Connelly, M. A., Shridas, P., van der Westhuyzen, D. R., and Webb, N. R. (2007) Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI J. Lipid Res. 48, 2560-2570 10.1194/jlr.M700163-JLR200
11. Kozarsky, K. F., Donahee, M. H., Rigotti, A., Iqbal, S. N., Edelman, E. R., and Krieger, M. (1997) Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels Nature 387, 414-417 10.1038/387414a0
12. Wang, N., Arai, T., Ji, Y., Rinninger, F., and Tall, A. R. (1998) Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice J. Biol. Chem. 273, 32920-32926 10.1074/jbc.273.49.32920
13. Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., and Krieger, M. (1997) A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proc. Natl. Acad. Sci. U. S. A. 94, 12610-12615 10.1073/pnas.94.23.12610
14. Van Eck, M., Twisk, J., Hoekstra, M., Van Rij, B. T., Van der Lans, C. A., Bos, I. S., Kruijt, J. K., Kuipers, F., and Van Berkel, T. J. (2003) Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver J. Biol. Chem. 278, 23699-23705 10.1074/jbc.M211233200
15. Marceau, P., Biron, S., Hould, F. S., Marceau, S., Simard, S., Thung, S. N., and Kral, J. G. (1999) Liver pathology and the metabolic syndrome X in severe obesity J. Clin. Endocrinol. Metab. 84, 1513-1517 10.1210/jcem.84.5.5661
16. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., and Melchionda, N. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50, 1844-1850 10.2337/diabetes.50.8.1844
17. Tilg, H. and Moschen, A. R. (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis Hepatology 52, 1836-1846 10.1002/hep.24001
18. Marchesini, G., Moscatiello, S., Di Domizio, S., and Forlani, G. (2008) Obesity-associated liver disease J. Clin. Endocrinol. Metab. 93, S74-S80 10.1210/jc.2008-1399
19. Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., and Sanyal, A. J. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55, 2005-2023 10.1002/hep.25762
20. Karavia, E. A., Papachristou, D. J., Liopeta, K., Triantaphyllidou, I. E., Dimitrakopoulos, O., and Kypreos, K. E. (2012) Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice Mol. Med. 18, 901-912 10.2119/molmed.2012.00113
21. Karavia, E. A., Papachristou, D. J., Kotsikogianni, I., Triantafyllidou, I. E., and Kypreos, K. E. (2013) Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice J. Nutr. Biochem. 24, 567-577 10.1016/j.jnutbio.2012.02.007
22. Duivenvoorden, I., Teusink, B., Rensen, P. C., Romijn, J. A., Havekes, L. M., and Voshol, P. J. (2005) Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice Diabetes 54, 664-671 10.2337/diabetes.54.3.664
23. Karagiannides, I., Abdou, R., Tzortzopoulou, A., Voshol, P. J., and Kypreos, K. E. (2008) Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice FEBS J. 275, 4796-4809 10.1111/j.1742-4658.2008.06619.x
24. Karavia, E. A., Papachristou, D. J., Kotsikogianni, I., Giopanou, I., and Kypreos, K. E. (2011) Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice FEBS J. 278, 3119-3129 10.1111/j.1742-4658.2011.08238.x
25. Aalto-Setala, K., Fisher, E. A., Chen, X., Chajek-Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H. N., and Breslow, J. L. (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles J. Clin. Invest. 90, 1889-1900 10.1172/JCI116066
26. Kypreos, K. E., Van Dijk, K. W., van der Zee, A., Havekes, L. M., and Zannis, V. I. (2001) Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion J. Biol. Chem. 276, 19778-19786 10.1074/jbc.M100418200
27. Constantinou, C., Mpatsoulis, D., Natsos, A., Petropoulou, P. I., Zvintzou, E., Traish, A. M., Voshol, P. J., Karagiannides, I., and Kypreos, K. E. (2014) The low density lipoprotein receptor modulates the effects of hypogonadism on diet-induced obesity and related metabolic perturbations J. Lipid Res. 55, 1434-1447 10.1194/jlr.M050047
28. Kypreos, K. E. (2008) ABCA1 Promotes the de Novo Biogenesis of Apolipoprotein CIII-Containing HDL Particles in Vivo and Modulates the Severity of Apolipoprotein CIII-Induced Hypertriglyceridemia Biochemistry 47, 10491-10502 10.1021/bi801249c
29. Commins, S. P., Watson, P. M., Padgett, M. A., Dudley, A., Argyropoulos, G., and Gettys, T. W. (1999) Induction of uncoupling protein expression in brown and white adipose tissue by leptin Endocrinology 140, 292-300 10.1210/endo.140.1.6399
30. Kobayashi, J., Applebaum-Bowden, D., Dugi, K. A., Brown, D. R., Kashyap, V. S., Parrott, C., Duarte, C., Maeda, N., and Santamarina-Fojo, S. (1996) Analysis of protein structure-function in vivo. Adenovirus-mediated transfer of lipase lid mutants in hepatic lipase-deficient mice J. Biol. Chem. 271, 26296-26301 10.1074/jbc.271.42.26296
31. Van Dijk, K. W., van Vlijmen, B. J., van't Hof, H. B., van Der, Z. A., Santamarina-Fojo, S., van Berkel, T. J., Havekes, L. M., and Hofker, M. H. (1999) In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE J. Lipid Res. 40, 336-344
32. Kypreos, K. E., Li, X., Van Dijk, K. W., Havekes, L. M., and Zannis, V. I. (2003) Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype Biochemistry 42, 9841-9853 10.1021/bi0271796
33. Tschop, M. H., Speakman, J. R., Arch, J. R., Auwerx, J., Bruning, J. C., Chan, L., Eckel, R. H., Farese, R. V., Jr., Galgani, J. E., Hambly, C., Herman, M. A., Horvath, T. L., Kahn, B. B., Kozma, S. C., Maratos-Flier, E., Muller, T. D., Munzberg, H., Pfluger, P. T., Plum, L., Reitman, M. L., Rahmouni, K., Shulman, G. I., Thomas, G., Kahn, C. R., and Ravussin, E. (2012) A guide to analysis of mouse energy metabolism Nat. Methods 9, 57-63 10.1038/nmeth.1806
34. Kypreos, K. E., Van Dijk, K. W., Havekes, L. M., and Zannis, V. I. (2005) Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia J. Biol. Chem. 280, 6276-6284 10.1074/jbc.M413458200
35. Havel, R. J., Kotite, L., Vigne, J. L., Kane, J. P., Tun, P., Phillips, N., and Chen, G. C. (1980) Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency J. Clin. Invest. 66, 1351-1362 10.1172/JCI109988
36. Rensen, P. C. and van Berkel, T. J. (1996) Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo J. Biol. Chem. 271, 14791-14799 10.1074/jbc.271.25.14791
37. Pardina, E., Lecube, A., Llamas, R., Catalan, R., Galard, R., Fort, J. M., Allende, H., Vargas, V., Baena-Fustegueras, J. A., and Peinado-Onsurbe, J. (2009) Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients Obes. Surg. 19, 1150-1158 10.1007/s11695-009-9853-3
38. Jiang, Z. G., Robson, S. C., and Yao, Z. (2013) Lipoprotein metabolism in nonalcoholic fatty liver disease J. Biomed. Res. 27, 1-13 10.7555/JBR.27.20120077
39. Choi, S. H. and Ginsberg, H. N. (2011) Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance Trends Endocrinol. Metab. 22, 353-363 10.1016/j.tem.2011.04.007
40. Li, X., Kypreos, K., Zanni, E. E., and Zannis, V. (2003) Domains of apoE required for binding to apoE receptor 2 and to phospholipids: Implications for the functions of apoE in the brain Biochemistry 42, 10406-10417 10.1021/bi027093c
41. Altmann, S. W., Davis, H. R., Jr., Yao, X., Laverty, M., Compton, D. S., Zhu, L. J., Crona, J. H., Caplen, M. A., Hoos, L. M., Tetzloff, G., Priestley, T., Burnett, D. A., Strader, C. D., and Graziano, M. P. (2002) The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1580, 77-93 10.1016/S1388-1981(01)00190-1
42. Rigotti, A., Trigatti, B. L., Penman, M., Rayburn, H., Herz, J., and Krieger, M. (1997) A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism Proc. Natl. Acad. Sci. U. S. A. 94, 12610-12615 10.1073/pnas.94.23.12610
43. Mahley, R. W. and Huang, Y. (1999) Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond Curr. Opin. Lipidol. 10, 207-217 10.1097/00041433-199906000-00003
44. Kuipers, F., Jong, M. C., Lin, Y., Eck, M., Havinga, R., Bloks, V., Verkade, H. J., Hofker, M. H., Moshage, H., Berkel, T. J., Vonk, R. J., and Havekes, L. M. (1997) Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes J. Clin. Invest. 100, 2915-2922 10.1172/JCI119841
45. Huang, Y., Liu, X. Q., Rall, S. C., Jr., Taylor, J. M., von Eckardstein, A., Assmann, G., and Mahley, R. W. (1998) Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia J. Biol. Chem. 273, 26388-26393 10.1074/jbc.273.41.26388
46. Tsukamoto, K., Maugeais, C., Glick, J. M., and Rader, D. J. (2000) Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice J. Lipid Res. 41, 253-259
47. Seo, T., Al-Haideri, M., Treskova, E., Worgall, T. S., Kako, Y., Goldberg, I. J., and Deckelbaum, R. J. (2000) Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1 J. Biol. Chem. 275, 30355-30362 10.1074/jbc.M910327199
48. Hu, L., van der Hoogt, C. C., Espirito Santo, S. M., Out, R., Kypreos, K. E., van Vlijmen, B. J., van Berkel, T. J., Romijn, J. A., Havekes, L. M., Van Dijk, K. W., and Rensen, P. C. (2008) The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI J. Lipid Res. 49, 1553-1561 10.1194/jlr.M800130-JLR200
49. Martineau, C., Kevorkova, O., Brissette, L., and Moreau, R. (2014) Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation Physiol. Rep. 2, e12117 10.14814/phy2.12117
50. Martineau, C., Martin-Falstrault, L., Brissette, L., and Moreau, R. (2014) The atherogenic Scarb1 null mouse model shows a high bone mass phenotype Am. J. Physiol Endocrinol. Metab 306, E48-E57 10.1152/ajpendo.00421.2013
51. Moller, C. L., Raun, K., Jacobsen, M. L., Pedersen, T. A., Holst, B., Conde-Frieboes, K. W., and Wulff, B. S. (2011) Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved Mol. Cell. Endocrinol. 341, 9-17 10.1016/j.mce.2011.03.010
52. Karavia, E. A., Zvintzou, E., Petropoulou, P. I., Xepapadaki, E., Constantinou, C., and Kypreos, K. E. (2014) HDL quality and functionality: what can proteins and genes predict? Expert Rev. Cardiovasc. Ther. 12, 521-532 10.1586/14779072.2014.896741
53. Marcel, Y. L., Weech, P. K., Nguyen, T. D., Milne, R. W., and McConathy, W. J. (1984) Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films Eur. J. Biochem. 143, 467-476 10.1111/j.1432-1033.1984.tb08394.x
54. Tsompanidi, E. M., Brinkmeier, M. S., Fotiadou, E. H., Giakoumi, S. M., and Kypreos, K. E. (2009) HDL biogenesis and functions: Role of HDL quality and quantity in atherosclerosis Atherosclerosis 208, 3-9 10.1016/j.atherosclerosis.2009.05.034
55. Kypreos, K. E., Gkizas, S., Rallidis, L. S., and Karagiannides, I. (2013) HDL particle functionality as a primary pharmacological target for HDL-based therapies Biochem. Pharmacol. 85, 1575-1578 10.1016/j.bcp.2013.03.004